- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 28, 2026 | 58.73M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 58.02M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 56.64M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $3.96M |
| Capex | Q1 2026 · Mar 31, 2025 | $1.94M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$12.53M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$18.52M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $104.25M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $90.81M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $670.93M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $656.16M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $89.42M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $101.28M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $222.4M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $237.33M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $485.75M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $474.98M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $893.33M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $893.49M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.34 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.32 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.34 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.32 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $92.94M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $70.67M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$19.78M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$18.15M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$19.86M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$20.68M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $117.23M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $82.35M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $33.34M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $24.32M |
| Revenue | Q1 2026 · Mar 31, 2026 | $150.57M |
| Revenue | Q1 2026 · Mar 31, 2025 | $106.66M |